Blockbuster weight-loss drug Wegovy is losing market share in the U.S. Here’s why
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy
Say goodbye to cheap versions of Ozempic and Wegovy
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
Wegovy could attract more male patients, here’s why
Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF poll
25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway
Wegovy is no longer just a weight-loss drug